Latest Technology News

Streamplay’s subsidiary Noodlecake has inked a three-year licensing agreement with Amazon to adapt and distribute one of its owned games on Amazon’s gaming platform, marking a strategic expansion into a new marketplace.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.

TruScreen Group Limited forecasts a robust 64% increase in FY26 sales, driven by strategic market expansions and new distribution agreements. The company’s AI-enabled cervical cancer screening technology is gaining traction across emerging markets.

TruScreen Group Limited has announced a NZ$3 million capital raise to fund strategic growth initiatives across Asia and Africa, alongside repaying existing debt. The raise includes a placement and share purchase plan with free attaching options, signaling confidence in its expanding cervical cancer screening programs.

Knosys Limited is reshaping its future by focusing on its Libero library management platform, aiming to become a global leader through strategic simplification, AI innovation, and geographic expansion.

Ionic Rare Earths has announced a $3 million capital raise via convertible notes, aimed at advancing its rare earth projects across multiple continents. The raise, pending shareholder approval, underscores the company’s strategic push into sustainable rare earth extraction and recycling technologies.

Elsight Limited has expanded its supply agreement with a European defence drone OEM to a total of US$9.63 million for 2025, positioning the company for profitability and cash flow break-even this year.

Clarity Pharmaceuticals has successfully imaged the first patient in its pivotal Phase III AMPLIFY trial for Cu-SAR-bisPSMA, a next-generation diagnostic agent targeting recurrent prostate cancer. This milestone sets the stage for potential FDA approval and broader clinical adoption.

Trigg Minerals has launched its maiden exploration program at the Antimony Canyon Project in Utah, aiming to unlock the potential of historically productive antimony mines with modern techniques.

Felix Gold Limited has confirmed its ability to produce premium-grade antimony concentrate with up to 69% purity from its Treasure Creek Project in Alaska, targeting production by late 2025. The results align with U.S. strategic mineral priorities amid a tightening global supply.

Xamble Group has acquired a 19% stake in Malaysia’s leading loyalty platform B Infinite, aiming to deepen influencer marketing engagement and unlock new revenue streams across Southeast Asia.